Results 201 to 210 of about 47,297 (213)

The Role of HER2/neu Overexpression/Amplification in the Progression of Ductal Carcinoma In Situ to Invasive Carcinoma of the Breast

Modern Pathology, 2002
F P O'Malley
exaly  

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

Lancet, The, 2003
W D George, Jack Cuzick, Catherine Duggan   +2 more
exaly  

Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

Cancer, 1995
William D Dupont, Lowell W Rogers, Roy A Jensen   +2 more
exaly  

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study

Lancet, The, 2007
Christiane K Kuhl, Simone Schrading, Eva Wardelmann   +2 more
exaly  

HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry

Histopathology, 2006
Eisei Shin
exaly  

Ductal Carcinoma In Situ of the Breast

Annual Review of Medicine, 2000
Melvin J Silverstein
exaly  

Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ

International Journal of Surgical Pathology, 2017
Gary Tozbikian, Edi Brogi, Dilip Giri
exaly  

Predictors of microinvasion and its prognostic role in ductal carcinoma in situ

American Journal of Surgery, 2013
Gloria R Sue, Donald R Lannin, Brigid Killelea   +2 more
exaly  

Ductal Carcinoma In Situ

New England Journal of Medicine, 2016
Andrea L. Merrill, Laura Esserman, Monica Morrow   +2 more
openaire   +1 more source

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy

Cancer, 2005
Laura C Collins, Rulla M Tamimi, James L Connolly   +2 more
exaly